Work

Abstract P3-03-15: Synergistic suppression of triple negative breast cancer with the combination of PI3K inhibitor (alpelisib, BYL719) and CDK inhibitor (ribociclib, LEE011)

Year: 2017

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs16-p3-03-15

Authors: Y Yuan, J Mortimer, Q Xing, J Yan, W Wen, E Han, JH Yim

Institutions: City Of Hope National Medical Center, City of Hope, Beckman Research Institute

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2592217904

Cites:

Cited by: 3

Related to: 10